| Health / Medical Topics |
ESO-1 (161-180) Peptide Vaccine
A recombinant 19-residue peptide vaccine consisting of amino acids 161 through 180 of the cancer/testis (CT) antigen. ESO-1 (161-180) peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for ESO-1, resulting in decreased tumor growth. ESO-1 is expressed in a variety of cancers, including melanoma, breast, bladder, prostate, and hepatocellular cancers. (NCI Thesaurus)
YOU MAY ALSO LIKE
The hydrochloride salt form of esmolol, a short and rapid-acting beta adrenergic antagonist belonging to the class II anti-arrhythmic drugs and devoid…
Human ESM1 wild-type allele is located in the vicinity of 5q11.2 and is approximately 8 kb in length. This allele, which encodes…
This gene may play a role in endothelial cell-leukocyte interactions.
The native people inhabiting the Arctic of northern Canada, Greenland, Alaska, or eastern Siberia. The two main groups referred to as Eskimo…
A rupture in the esophageal wall caused by traumatic or pathologic processes.
A regimen consisting of etoposide, methylprednisolone, high-dose cytarabine and cisplatin, used to treat relapsed and refractory Hodgkin's and non-Hodgkin's lymphoma.
